SERA-SCANDIA A/S: Financial statements 2014
CVR: 14605185
Source: annual report 2014, Danish Business Authority
01/04/2013 – 31/03/2014
SERA-SCANDIA A/S (CVR 14605185) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 72,559 and a net result of DKK -3,512,674 compared with DKK -8,816,471 the year before. The profit margin was -4,841.1%. Equity in the 2014 report amounted to DKK 32,680,455. The solvency ratio was 70%.
- Revenue
- DKK 72,559
- Gross Profit
- DKK 52,234
- Profit/Loss
- DKK -3,512,674
- Equity
- DKK 32,680,455
- Total Assets
- DKK 46,688,194
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout SERA-SCANDIA A/S
SERA-SCANDIA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1990. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SERA-SCANDIA ApS and VICH 2604 ApS. The management consists of Troels Zakarias Glahn Kristiansen. The board consists of Ole Bødtker Nielsen (chair), Christian Lykkehus Sørensen and Nicolas Bødtker Nielsen. The company is owned by Danbiotech Inc.. The company has 16 employees (2026). In 2025, the company reported a gross profit of DKK 40,586,000 and a net result of DKK -7,801,000 compared with DKK 2,203,000 the year before. Equity in the 2025 report amounted to DKK 272,104,000.